Mycobacterium tuberculosis bloodstream infection prevalence, diagnosis, and mortality risk in seriously ill adults with HIV: a systematic review and meta-analysis of individual patient data
<strong>Background</strong> The clinical and epidemiological significance of HIV-associated Mycobacterium tuberculosis bloodstream infection (BSI) is incompletely understood. We hypothesised that M tuberculosis BSI prevalence has been underestimated, that it independently predicts death,...
Հիմնական հեղինակներ: | Barr, DA, Lewis, JM, Feasey, N, Schutz, C, Kerkhoff, AD, Jacob, ST, Andrews, B, Kelly, P, Lakhi, S, Muchemwa, L, Bacha, HA, Hadad, DJ, Bedell, R, van Lettow, M, Zachariah, R, Crump, JA, Alland, D, Corbett, EL, Gopinath, K, Singh, S, Griesel, R, Maartens, G, Mendelson, M, Ward, AM, Parry, CM, Talbot, EA, Munseri, P, Dorman, SE, Martinson, N, Shah, M, Cain, K, Heilig, CM, Varma, JK, von Gottberg, A, Sacks, L, Wilson, D, Squire, SB, Lalloo, DG, Davies, G, Meintjes, G |
---|---|
Ձևաչափ: | Journal article |
Լեզու: | English |
Հրապարակվել է: |
Elsevier
2020
|
Նմանատիպ նյութեր
-
Standard-dose versus double-dose dolutegravir in HIV-associated tuberculosis in South Africa (RADIANT-TB): a phase 2, non-comparative, randomised controlled trial
: Griesel, R, և այլն
Հրապարակվել է: (2023) -
Recycling tenofovir in second-line antiretroviral treatment with dolutegravir: outcomes and viral load trajectories to 72 weeks
: Keene, CM, և այլն
Հրապարակվել է: (2023) -
Initial supplementary dose of dolutegravir in second-line antiretroviral therapy: a noncomparative, double-blind, randomized placebo-controlled trial
: Zhao, Y, և այլն
Հրապարակվել է: (2023) -
C-reactive protein and procalcitonin to discriminate between tuberculosis, Pneumocystis jirovecii pneumonia, and bacterial pneumonia in HIV-infected inpatients meeting WHO criteria for seriously ill: a prospective cohort study
: Fiona Mendelson, և այլն
Հրապարակվել է: (2018-08-01) -
Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line antiretroviral therapy in adults failing a tenofovir-based first-line regimen
: Keene, CM, և այլն
Հրապարակվել է: (2021)